Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID12844 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12845 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12846 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12847 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12848 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12849 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12850 | GDSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPV | Isoform 1 of Fibrinogen alpha chain precursor | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12851 | EAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGPHCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES | Platelet factor 4 | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12852 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12853 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12854 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12855 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12856 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12857 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12858 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12859 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12860 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12861 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12862 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12863 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12864 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12865 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12866 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12867 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12868 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12869 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12870 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12871 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12872 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12873 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12874 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12875 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12876 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12877 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12878 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12879 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12880 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12881 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12882 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12883 | HGFESGDFVSFSEVQGMVELNGNQPMEIK | Ubiquitin-like modifier activating enzyme 1 | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12884 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12885 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12886 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12887 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12888 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12889 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Downregulated in AML vs healthy | 23915341 |
| CancerPDF_ID12890 | NA | NA | Serum | NA | MALDI-TOF | Acute myeloid leukemia (AML) | Upregulated in AML vs healthy | 23915341 |